127 related articles for article (PubMed ID: 19939211)
1. Emerging drugs for irritable bowel syndrome.
Shekhar C; Whorwell PJ
Expert Opin Emerg Drugs; 2009 Dec; 14(4):673-85. PubMed ID: 19939211
[TBL] [Abstract][Full Text] [Related]
2. Desperately seeking serotonin... A commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders.
Pasricha PJ
Gastroenterology; 2007 Jun; 132(7):2287-90. PubMed ID: 17570201
[No Abstract] [Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome.
Camilleri M
Clin Pharmacol Ther; 2012 Jan; 91(1):44-59. PubMed ID: 22071696
[No Abstract] [Full Text] [Related]
5. [Irritable bowel syndrome: issues of diagnosis and treatment efficiency].
Loranskaia ID
Eksp Klin Gastroenterol; 2008; (1):90-5. PubMed ID: 19145859
[No Abstract] [Full Text] [Related]
6. Irritable bowel syndrome: new pharmaceutical approaches to treatment.
Farthing MJ
Baillieres Best Pract Res Clin Gastroenterol; 1999 Oct; 13(3):461-71. PubMed ID: 10580922
[TBL] [Abstract][Full Text] [Related]
7. Treatment options in irritable bowel syndrome.
Farthing MJ
Best Pract Res Clin Gastroenterol; 2004 Aug; 18(4):773-86. PubMed ID: 15324713
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis: The treatment of irritable bowel syndrome.
Lesbros-Pantoflickova D; Michetti P; Fried M; Beglinger C; Blum AL
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1253-69. PubMed ID: 15606387
[TBL] [Abstract][Full Text] [Related]
9. [Treatment experience of patients with irritable bowel syndrome complicated by constipations with medicinal preparation softovak].
Ruchkina IN; Lychkova AE; Parfenov AI
Eksp Klin Gastroenterol; 2007; (5):103-6. PubMed ID: 18389606
[No Abstract] [Full Text] [Related]
10. Review article: the overlap between functional dyspepsia and irritable bowel syndrome -- a tale of one or two disorders?
Cremonini F; Talley NJ
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():40-9. PubMed ID: 15521854
[TBL] [Abstract][Full Text] [Related]
11. Therapy options in irritable bowel syndrome.
Enck P; Junne F; Klosterhalfen S; Zipfel S; Martens U
Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1402-11. PubMed ID: 21389791
[TBL] [Abstract][Full Text] [Related]
12. [Tegaserod in treatment of women with irritable bowel syndrome].
Munck LK; Ainsworth MA
Ugeskr Laeger; 2007 Jun; 169(23):2190-2. PubMed ID: 17592683
[TBL] [Abstract][Full Text] [Related]
13. Irritable bowel syndrome: new and emerging therapies.
Harris LA; Chang L
Curr Opin Gastroenterol; 2006 Mar; 22(2):128-35. PubMed ID: 16462168
[TBL] [Abstract][Full Text] [Related]
14. The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study.
Bardhan KD; Forbes A; Marsden CL; Mason T; Short G
Aliment Pharmacol Ther; 2004 Jul; 20(2):213-22. PubMed ID: 15233702
[TBL] [Abstract][Full Text] [Related]
15. Managing irritable bowel syndrome without special drugs. Another IBS drug has been taken off the market because of serious side effects. Now what?
Harv Womens Health Watch; 2007 Jun; 14(10):3-4. PubMed ID: 18018315
[No Abstract] [Full Text] [Related]
16. [Recent insights into the pathogenesis of abdominal symptoms in functional bowel disorders].
Cervio E; Rondanelli M; Balestra B; Dellabianca A; Agazzi A; Giacosa A; Tonini M
Recenti Prog Med; 2007 Feb; 98(2):69-73. PubMed ID: 17439064
[TBL] [Abstract][Full Text] [Related]
17. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
Prescrire Int; 2009 Apr; 18(100):75-9. PubMed ID: 19585728
[TBL] [Abstract][Full Text] [Related]
18. Effect of long-term treatment with octreotide on rectal sensitivity in patients with non-constipated irritable bowel syndrome.
Klooker TK; Kuiken SD; Lei A; Boeckxstaens GE
Aliment Pharmacol Ther; 2007 Aug; 26(4):605-15. PubMed ID: 17661764
[TBL] [Abstract][Full Text] [Related]
19. A review of irritable bowel syndrome and an update on therapeutic approaches.
Bassett JT; Cash BD
Expert Opin Pharmacother; 2008 May; 9(7):1129-43. PubMed ID: 18422471
[TBL] [Abstract][Full Text] [Related]
20. Tegaserod for constipation-predominant irritable bowel syndrome.
Kale-Pradhan PB; Wilhelm SM
Pharmacotherapy; 2007 Feb; 27(2):267-77. PubMed ID: 17253916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
